Marshall Wace’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-79,081
| Closed | -$7.6M | – | 3511 |
|
|
2025
Q4 | $7.6M | Sell |
79,081
-130,690
| -62% | -$12.7M | 0.01% | 974 |
|
|
2025
Q3 | $20M | Buy |
209,771
+49,397
| +31% | +$4.54M | 0.02% | 653 |
|
|
2025
Q2 | $14M | Buy |
160,374
+155,824
| +3,425% | +$13.2M | 0.02% | 710 |
|
|
2025
Q1 | $409K | Sell |
4,550
-403,773
| -99% | -$36.1M | ﹤0.01% | 2155 |
|
|
2024
Q4 | $32.6M | Buy |
408,323
+301,074
| +281% | +$26.1M | 0.04% | 397 |
|
|
2024
Q3 | $9.66M | Sell |
107,249
-160,687
| -60% | -$13.5M | 0.01% | 776 |
|
|
2024
Q2 | $21.1M | Buy |
267,936
+247,213
| +1,193% | +$20.3M | 0.03% | 481 |
|
|
2024
Q1 | $1.81M | Buy |
20,723
+11,005
| +113% | +$939K | ﹤0.01% | 1415 |
|
|
2023
Q4 | $801K | Sell |
9,718
-1,220
| -11% | -$93K | ﹤0.01% | 1551 |
|
|
2023
Q3 | $857K | Sell |
10,938
-541,162
| -98% | -$45.3M | ﹤0.01% | 1553 |
|
|
2023
Q2 | $48.6M | Buy |
552,100
+429,502
| +350% | +$37M | 0.1% | 218 |
|
|
2023
Q1 | $9.88M | Sell |
122,598
-437,912
| -78% | -$35.7M | 0.02% | 715 |
|
|
2022
Q4 | $43.6M | Sell |
560,510
-1,205,190
| -68% | -$97.7M | 0.1% | 228 |
|
|
2022
Q3 | $143M | Buy |
1,765,700
+163,062
| +10% | +$14.7M | 0.31% | 51 |
|
|
2022
Q2 | $144M | Buy |
1,602,638
+1,372,189
| +595% | +$139M | 0.3% | 65 |
|
|
2022
Q1 | $25.6M | Sell |
230,449
-141,685
| -38% | -$15M | 0.05% | 410 |
|
|
2021
Q4 | $38.5M | Buy |
372,134
+221,428
| +147% | +$25.6M | 0.07% | 278 |
|
|
2021
Q3 | $18.9M | Buy |
150,706
+71,818
| +91% | +$9.3M | 0.08% | 284 |
|
|
2021
Q2 | $9.79M | Sell |
78,888
-5,852
| -7% | -$735K | 0.04% | 495 |
|
|
2021
Q1 | $10M | Sell |
84,740
-189,379
| -69% | -$22.2M | 0.05% | 448 |
|
|
2020
Q4 | $32.1M | Sell |
274,119
-554,526
| -67% | -$61M | 0.17% | 117 |
|
|
2020
Q3 | $86.1M | Buy |
+828,645
| New | +$83.2M | 0.55% | 30 |
|
|
2020
Q1 | – | Sell |
-102,255
| Closed | -$11.6M | – | 1888 |
|
|
2019
Q4 | $11.6M | Buy |
+102,255
| New | +$11.2M | 0.08% | 294 |
|
|
2019
Q2 | – | Sell |
-112,270
| Closed | -$10.2M | – | 1635 |
|
|
2019
Q1 | $10.2M | Buy |
112,270
+75,372
| +204% | +$6.75M | 0.1% | 254 |
|
|
2018
Q4 | $3.36M | Buy |
36,898
+13,936
| +61% | +$1.3M | 0.03% | 585 |
|
|
2018
Q3 | $2.26M | Buy |
+22,962
| New | +$2.12M | 0.02% | 654 |
|
|
2017
Q1 | – | Sell |
-32,309
| Closed | -$2.3M | – | 570 |
|
|
2016
Q4 | $2.3M | Sell |
32,309
-738,310
| -96% | -$58M | 0.02% | 608 |
|
|
2016
Q3 | $66.6M | Sell |
770,619
-358,738
| -32% | -$31.3M | 0.47% | 50 |
|
|
2016
Q2 | $98M | Sell |
1,129,357
-139,934
| -11% | -$11.3M | 0.82% | 19 |
|
|
2016
Q1 | $95.2M | Buy |
1,269,291
+667,890
| +111% | +$50.3M | 0.92% | 17 |
|
|
2015
Q4 | $46.3M | Sell |
601,401
-535,144
| -47% | -$40.3M | 0.43% | 62 |
|
|
2015
Q3 | $76.1M | Sell |
1,136,545
-131,311
| -10% | -$9.67M | 0.93% | 16 |
|
|
2015
Q2 | $93.9M | Buy |
1,267,856
+943,451
| +291% | +$72.1M | 1.23% | 7 |
|
|
2015
Q1 | $25.3M | Buy |
324,405
+237,405
| +273% | +$18M | 0.33% | 82 |
|
|
2014
Q4 | $6.28M | Sell |
87,000
-97,751
| -53% | -$6.79M | 0.08% | 270 |
|
|
2014
Q3 | $11.4M | Buy |
+184,751
| New | +$11.7M | 0.17% | 163 |
|
|
2014
Q2 | – | Sell |
-82,916
| Closed | -$5.1M | – | 1011 |
|
|
2014
Q1 | $5.1M | Buy |
+82,916
| New | +$4.83M | 0.09% | 233 |
|
Other funds holding MDT
VCM
VPM
Marshall Wace's MDT Position: Q1 2026 in Review
Marshall Wace sold out of Medtronic (MDT) in Q1 2026, closing a stake of 79,081 shares — an estimated $7.6M sold.
Marshall Wace first reported a position in MDT in Q1 2014 and held it in 37 quarters. The position peaked at $144M in Q2 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Marshall Wace reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Marshall Wace sold 79,081 Medtronic shares in Q1 2026, an estimated $7.6M.
- Marshall Wace first reported a position in Medtronic in Q1 2014 and held it in 37 quarters.
- Marshall Wace's Medtronic position peaked at $144M in Q2 2022.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.